logo

Acurx Pharmaceuticals, Inc (ACXP)



Trade ACXP now with
  Date
  Headline
11/14/2022 7:24:10 AM Acurx Pharmaceuticals Q3 Net Loss/shr $0.32 Vs. Loss/shr $0.46 Last Year
8/15/2022 7:30:51 AM Acurx Pharmaceuticals, Inc. Q2 Net Loss/shr $0.26 Vs. Loss/shr $0.57 Last Year
7/25/2022 8:32:41 AM Acurx Pharma Announces $4.225 Mln Registered Direct Offering
5/11/2022 7:25:01 AM Acurx Pharma Q1 Net Loss $2.7 Mln Or $0.26/Shr Vs Loss Of $1.5 Mln Or $0.21/shr Last Year
3/17/2022 7:16:12 AM Acurx Pharma FY Net Loss $12.75 Mln Or $1.49/Shr Vs Loss $4.6 Mln Or $0.74/Shr Last Year
11/1/2021 8:08:41 AM Acurx Announces New Microbiome Data From Its Phase 2a Clinical Trial Of Ibezapolstat For C. Difficile Infection
10/4/2021 11:25:14 AM Acurx Pharma Down 11%
9/27/2021 8:27:30 AM Acurx Announces New Microbiome Data From Phase 2a Trial Of Ibezapolstat For CDI; Advancing To Phase 2b